Autori: Shmueli E
| Naslov | Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) (Meeting Abstract) |
| Autori | Ciuleanu Tudor E Nikolic Vladimir Shmueli E Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank M Purkalne Gunta Brodowicz Thomas Zielinski Christoph |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2011), vol. 29 br. 15, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Cetuximab weekly (q1w) versus every two weeks (q2w) plus FOLFOX4 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC). (Meeting Abstract) |
| Autori | Ciuleanu Tudor E Nikolic Vladimir Shmueli E Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank Magdolna Purkalne Gunta Brodowicz Thomas Zielinski Christoph |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2011), vol. 29 br. 4, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
